中基長壽科學(00767.HK)獲聯交所函件維持暫停股份買賣決定
中基長壽科學(00767.HK)公布,有關上市委員會要求公司股份暫停買賣的決定,覆核聆訊已於今年3月15日由委員會進行。於昨日(30日),公司接獲聯交所函件,獲悉經考慮公司及上市科之全部提交資料,委員會認為,公司未能根據上市規則第13.24條規定維持足夠程度之業務運作及資產,以保證其股份維持上市地位,故決定維持上市科要求公司股份根據第6.01(3)條暫停買賣的決定。
委員會達致其決定理由包括於去年之前,公司主要從事P2P業務和放債業務。公司在2020年決定停止P2P業務,而放債業務在2019年開始轉差,並在去年上半年下降至最低水平。其後,公司開始並尋求依靠長壽科學業務以符合上市規則第13.24條。然而,該業務的經營歷史尚短,目前經營規模有限。在很大程度上依賴閆先生,而且業務計劃欠缺細節,亦不可信。委員會認為,公司未能證明其擁有可行和可持續的實質業務。
公司有權於今年4月11日或之前將上市委員會決定轉交至上市覆核委員會以供其覆核。除非公司根據其權利申請覆核上市委員會決定,否則股份將於今年4月12日起暫停買賣。公司指,正在覆核上市委員會決定,就其於內部及與專業顧問進行討論,並將考慮是否提交要求將上市委員會決定轉交至上市覆核委員會以供其覆核。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.